Trial Profile
Clinical Trials Insight: 700028212
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Mar 2024
Price :
$35
*
At a glance
- Drugs Agatolimod (Primary) ; Tremelimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Sponsors Coley Pharmaceutical GmbH